RARE
RARE
NASDAQ · Biotechnology

Ultragenyx Pharmaceutical In

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$27.44
+0.53 (+1.97%)
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 22 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +171.3% upside
Low Target $68.49
Average Target $74.44
High Target $103.74
Current Price $27.44
Current
$27.44
Target
$74.44
$68.49 $74.44 avg $103.74
Scenario Analysis
Bear Case
$68.49
149.6%
Low target
Base Case
$74.44
+171.3%
Avg target
Bull Case
$103.74
+278.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$42.37
-35.2% from high
52-Week Low
$18.29
+50.0% from low
50-Day SMA
$26.56
+3.3% vs SMA
200-Day SMA
$31.06
-11.7% vs SMA
RSI (14)
37.4
Neutral
Target vs 52W High
$74.44
+75.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%